The Board of Directors considered and approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2025 for F.Y. 2025-26 as reviewed ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Chemcrux Enterprises Ltd, at its meeting held on 05th February 2026, approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2025 (Q3 and 9M FY26). The results were reviewed and recommended by the Audit Committee, and a Limited Review Report was issued by the statutory auditors, Naresh & Co., Chartered Accountants. The meeting was held at the registered office in Vadodara, Gujarat, and ran from 11:30 AM to 1:35 PM. No specific financial figures or commentary were disclosed in this filing.
This is a routine regulatory disclosure confirming that quarterly results have been approved as expected, with no unexpected items or red flags flagged in the filing itself. Shareholders should review the actual financial results (revenue, profit, margins) once separately published to assess the stock's true implications.